Antirobe 25 mg 80 caps

SKU
180311
Marque:
Pfizer
Batch:
B769204
Expiry date:
30-Sep-2027
Numéro d'enregistrement:
FR/V/2992805 3/1989 - BE: BE-V155102

Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.

Capsules for dogs and cats containing clindamycin.

Plus de détails

Avertissement : le produit sur la photo peut différer du produit réel.

Antirobe 25mg 80caps

Key benefits

  • Concentrates in leukocytes, quickly reaching the infection site to treat intracellular pathogens.
  • Activity against susceptible strains of aerobic and anaerobic bacteria.
  • Maintains full antimicrobial activity in purulent environments.
  • Penetrates biofilms found in both dental and bone infections.
  • No reconstitution or refrigeration needed.
  • Convenient once-a-day dosing for cats.

Antirobe is indicated for:
Dogs
The treatment of skin infections (wounds and abscesses) due to coagulase positive staphylococci (Staphylococcus aureus or Staphylococcus intermedius). Deep wounds and abscesses due to Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.
Dental infections due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.
Osteomyelitis due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.

Cats
The treatment of skin infections (wounds and abscesses) due to Staphylococcus aureus, Staphylococcus intermedius, Streptococcus spp. Deep wounds and infections due to Clostridium perfringens and Bacteroides fragilis.
Dental infections due to Staphylococcus aureus, Staphylococcus intermedius, Streptococcus spp., Clostridium perfringens and Bacteroides fragilis.

 

© 2024 Grovet B.V. All rights reserved.